Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Fluent Corp.
FLUENT Reports First Quarter 2025 Results
Published May 29 2025
12 min read

FLUENT Reports First Quarter 2025 Results

news images

- Q1 Revenue Grew 5.91% YoY to $26.7 million
- Ended quarter with $30.7 million of cash and cash equivalents
- New York operations continuing to progress as Buffalo cultivation facility nears completion

TAMPA, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the first quarter ended March 31, 2025. Unless otherwise indicated, all financial results are presented in U.S. dollars.

Management Commentary

“In Q1 2025, we generated $26.7 million in revenue, a 5.9% increase year-over-year, despite continued price compression and increased market saturation in Florida,” said Robert Beasley, Chief Executive Officer of FLUENT. “While adjusted EBITDA declined to $3.5 million, largely due to softness in Florida, our core fundamentals remain strong. We continue to invest in infrastructure and brand development to support long-term growth. Despite industry-wide challenges this quarter, we remained focused on disciplined execution.”

Beasley added, “In New York, integration of the RIV Capital assets is progressing well, with the Buffalo cultivation facility nearing completion and the FLUENT retail rebrand underway. In Florida, we launched new products and completed construction of the Roza facility, expanding production capacity ahead of our next planned harvest. Our cash position of $30.7 million, up from $8.5 million a year ago, gives us the flexibility to support near-term priorities and long-term growth.”

He concluded, “While macro and regulatory uncertainties remain, we are focused on strengthening our core markets, managing costs, and positioning the company to adapt and grow as market conditions evolve.”

Q1 2025 Financial Highlights (vs. Q1 2024)

  • Revenue was $26.7 million compared to $25.2 million.

  • Florida revenue was $19.2 million compared to $21.1 million.

  • Gross profit before fair value adjustments1 was $12.5 million or 46.8% of revenue, compared to $12.3 million or 48.6% of revenue.

  • Adjusted EBITDA was $3.5 million compared to $6.8 million, reflecting the ongoing startup and ramp-up in the New York market following the RIV acquisition, as well as continued softness in the Florida market.

  • Cash flow used in operations for the three months ending March 31, 2025, was $1.5 million compared to cash flow provided by operations of $4.1 million in the prior year. The decline is primarily attributable to the settlement of payments that had been carried over from previous periods.

  • On March 31, 2025, the Company had approximately $30.7 million of cash and cash equivalents and $79.1 million of total debt outstanding, with approximately 700 million shares outstanding on an as-converted basis, compared to $8.5 million of cash and cash equivalents and $62.9 million of total debt, with approximately 300 million shares outstanding on March 31, 2024.

Recent Operational Highlights

Company Footprint:

  • As of the end of the reporting period, FLUENT operates a total of 42 retail locations and 8 production facilities across its key markets of Florida, New York, Pennsylvania, and Texas.

Florida:

  • Currently operating thirty-five retail locations and five production facilities.

  • On track to opening three additional stores in Florida by the end of 2025.

  • Successfully relocated the North Miami Beach dispensary to Aventura, offering more points of sale, larger vault storage, and a refreshed store design.

  • Completed construction of the new Rosa cultivation facility in Tampa; cultivation commenced in early May with the first harvest expected in August 2025.

  • Launched two differentiated whole flower brands:

    • KNACK – a high-quality, affordable offering.

    • Bag-O – a value-driven line available in larger formats.

  • Introduced 10mg THC chocolate bites, FLUENT’s first single-serve edible product.

New York:

  • Currently operating four retail locations and one production facility.

  • Construction of Buffalo, our second cultivation facility in New York, is nearing completion. The first planting is expected in Q2 2025, with the inaugural harvest projected for Q4 2025.

  • Initiated rebranding of New York retail locations to FLUENT following the successful acquisition of RIV Capital assets.

  • Expanded the KNACK brand portfolio in New York to include pre-rolls, alongside a rotating selection of whole flower strains.

Texas:

  • Currently operating one production facility and a delivery program.

  • Commenced construction of the Houston Education and Pick-Up Center, with an expected opening in Q3 2025.

Pennsylvania:

  • Currently operating three retail locations in the state.

The company is actively monitoring legislative developments and is encouraged by the accelerating momentum toward adult-use legalization in Pennsylvania and the potential expansion of the medical program in Texas, both of which represent promising future growth catalysts.

_____________________________
1 Gross profit before fair value adjustments is a non-IFRS financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies. The Company calculates gross profit before fair value adjustments from gross profit plus (minus) the changes in fair value of biological assets, as presented in the consolidated statement of operations.

Conference Call

The Company will host a conference call and live audio webcast today at 4:30 p.m. Eastern time to discuss its financial and operational results, followed by a question-and-answer period.

Date: Thursday, May 29, 2025
Time: 4:30 p.m. Eastern time
Toll-free dial-in number: 1-844-763-8274 (toll -free)
International dial-in number: 1-412-717-9224 (international)

Join Instructions: Participants to ask to be joined into the FLUENT Corp. call.

Link: FLUENT Corp Conference Call

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization.

The conference call will also be available for replay for up to two weeks via the News & Events section of the Company’s investor relations website at https://investors.getFLUENT.com/.

Forward-Looking Information
Certain information in this news release may constitute forward-looking information within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent the Company's expectations, estimates, and projections regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control.

Forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available on its SEDAR+ profile at www.sedarplus.ca. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

For further information visit: https://getfluent.com/ and https://investors.getFLUENT.com/

Investor Relations Contact
investors@getFLUENT.com

Media Contact:
press@getfluent.com

Officer Contact:
Robert Beasley, CEO
(850) 972-8077

 

Fluent Corp.

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

As of March 31, 2025 and December 31, 2024

(USD '000)

 

March 31,
2025

 

December 31,
2024

 

 

 

 

Assets

 

 

 

Current assets

 

 

 

Cash and cash equivalents

$

30,744

 

 

$

40,106

 

Accounts receivable

 

235

 

 

 

422

 

Biological assets

 

3,298

 

 

 

3,162

 

Inventory, net

 

20,051

 

 

 

15,155

 

Prepaid expenses and other current assets

 

1,824

 

 

 

2,587

 

Total current assets

$

56,152

 

 

$

61,432

 

 

 

 

 

Property and equipment, net

 

53,757

 

 

 

52,200

 

Intangible assets, net

 

37,315

 

 

 

37,590

 

Right-of-use assets, net

 

45,523

 

 

 

46,731

 

Goodwill

 

1,525

 

 

 

1,525

 

Deferred tax assets

 

1,248

 

 

 

1,039

 

Other assets

 

6,534

 

 

 

6,476

 

Total assets

$

202,053

 

 

$

206,992

 

 

 

 

 

Liabilities and shareholders' equity

 

 

 

Current liabilities

 

 

 

Accounts payable

$

4,439

 

 

$

6,331

 

Accrued expenses

 

8,923

 

 

 

8,423

 

Income taxes payable

 

1,003

 

 

 

1,003

 

Derivative liabilities

 

1,691

 

 

 

2,148

 

Short term provision liability

 

5,000

 

 

 

4,957

 

Current portion of notes payable

 

458

 

 

 

755

 

Lease obligations - current portion

 

4,943

 

 

 

4,751

 

Total current liabilities

$

26,457

 

 

$

28,368

 

 

 

 

 

Long-term liabilities

 

 

 

Notes payable, net of current portion and financing costs

 

69,261

 

 

 

68,775

 

Lease obligations, net of current portion

 

51,168

 

 

 

51,727

 

Deferred tax liability

 

5,542

 

 

 

4,817

 

Uncertain tax position

 

48,176

 

 

 

43,314

 

Long term provision liability

 

8,980

 

 

 

9,044

 

Convertible notes, net

 

6,729

 

 

 

6,482

 

Other long-term liabilities

 

3,447

 

 

 

3,447

 

Total long-term liabilities

$

193,303

 

 

$

187,606

 

Total liabilities

$

219,760

 

 

$

215,974

 

 

 

 

 

Shareholders' equity

 

 

 

Share capital

 

206,419

 

 

 

206,419

 

Share-based compensation reserve

 

7,300

 

 

 

7,275

 

Equity conversion feature

 

7,097

 

 

 

7,097

 

Warrants

 

29,634

 

 

 

29,634

 

Accumulated deficit

 

(266,961

)

 

 

(258,211

)

Accumulated other comprehensive income (loss)

 

(1,196

)

 

 

(1,196

)

Total shareholders' equity

 

(17,707

)

 

 

(8,982

)

 

 

 

 

Total liabilities and shareholders' equity

$

202,053

 

 

$

206,992

 

 

 

 

 


 

Fluent Corp.

CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)

For the three months ended March 31, 2025 and March 31, 2024

(USD '000)

For the three months ended

 

March 31,
2025

 

March 31,
2024

 

 

 

 

Revenue, net

$

26,717

 

 

$

25,227

 

Cost of goods sold

 

14,195

 

 

 

12,966

 

Gross profit before fair value adjustments

 

12,522

 

 

 

12,261

 

 

 

 

 

Fair value adjustments on inventory sold

 

(301

)

 

 

1,628

 

Unrealized gain (loss) on changes in fair value of biological assets

 

3,025

 

 

 

1,047

 

Gross profit

 

15,246

 

 

 

14,936

 

 

 

 

 

Operating expenses:

 

 

 

General and administrative

 

4,894

 

 

 

3,963

 

Sales and marketing

 

6,319

 

 

 

5,434

 

Depreciation and amortization

 

2,025

 

 

 

1,730

 

Share-based compensation

 

25

 

 

 

49

 

Total operating expenses

 

13,263

 

 

 

11,176

 

 

 

 

 

Income from operations

 

1,982

 

 

 

3,760

 

 

 

 

 

Other expense (income):

 

 

 

Finance costs, net

 

4,423

 

 

 

4,711

 

Gain on change in fair value of derivative liability

 

(457

)

 

 

(1,687

)

Loss on disposal of assets

 

-

 

 

 

212

 

Other expense, net

 

12

 

 

 

2

 

Total other expense

 

3,978

 

 

 

3,238

 

 

 

 

 

Net income (loss) before income taxes

 

(1,996

)

 

 

522

 

 

 

 

 

Income tax expense

 

6,754

 

 

 

4,685

 

 

 

 

 

Comprehensive income (loss)

$

(8,750

)

 

$

(4,163

)

 

 

 

 

Net loss per share - basic and diluted

$

(0.02

)

 

$

(0.01

)

 

 

 

 

 

 

 

 


 

Fluent Corp.

CONSOLIDATED STATEMENTS OF CASH FLOW

For the three months ended March 31, 2025 and March 31, 2024

(USD '000)

 

For the three months ended

 

March 31,
2025

 

March 31,
2024

 

 

 

 

Cash flows used in operating activities

 

 

 

Net loss

$

(8,750

)

 

$

(4,163

)

 

 

 

 

Adjustments for non-cash items:

 

 

 

Bargain purchase gain on business combination

 

 

 

Loss on issuance and extinguishment of debt instruments, net

 

 

 

Intangible assets impairment

 

 

 

Unrealized (gain) loss on changes in fair value of biological assets

 

(3,025

)

 

 

(1,047

)

Realized (gain) loss on fair value amounts included in inventory sold

 

301

 

 

 

(1,628

)

Share-based compensation expense

 

25

 

 

 

49

 

Depreciation and amortization

 

4,553

 

 

 

3,703

 

Accretion and interest expense

 

4,332

 

 

 

4,686

 

Net change in fair value of derivative

 

(457

)

 

 

(1,687

)

Loss on dispositions of fixed assets

 

-

 

 

 

212

 

Uncertain tax position

 

4,862

 

 

 

-

 

Deferred tax expense

 

516

 

 

 

1,216

 

Changes in non-cash working capital

 

 

 

Accounts receivable

 

187

 

 

 

(17

)

Inventory

 

3,279

 

 

 

3,939

 

Biological assets

 

(5,587

)

 

 

(3,551

)

Prepaid expenses and other current assets

 

763

 

 

 

747

 

Right of use assets / liabilities

 

(1,000

)

 

 

(1,317

)

Other assets

 

(58

)

 

 

(90

)

Accounts payable

 

(1,892

)

 

 

630

 

Accrued expenses

 

500

 

 

 

(4,192

)

Income taxes

 

-

 

 

 

6,938

 

Other long-term liabilities

 

-

 

 

 

(375

)

Net cash provided by operating activities

$

(1,451

)

 

$

4,053

 

 

 

 

 

Cash flows used in investing activities

 

 

 

Purchase of property and equipment

$

(4,179

)

 

$

(2,948

)

Net cash provided by used in investing activities

$

(4,179

)

 

$

(2,948

)

 

 

 

 

Cash flows provided by used in financing activities

 

 

 

Principal repayments of notes payable

 

(2,681

)

 

 

(2,340

)

Payment of lease obligations

 

(1,051

)

 

 

(765

)

Net cash used in financing activities

$

(3,732

)

 

$

(3,105

)

 

 

 

 

Net decrease in cash and cash equivalents

$

(9,362

)

 

$

(2,000

)

 

 

 

 

Cash, beginning of period

 

40,106

 

 

 

10,521

 

 

 

 

 

Cash, end of period

$

30,744

 

 

$

8,521

 

 

 

 

 


 

Fluent Corp.

EBITDA AND ADJUSTED EBITDA CALCULATION

For the three months ended March 31, 2025 and March 31, 2024

(USD '000)

 

 

 

 

For the three months ended

 

March 31,
2025

 

March 31,
2024

Net loss

$

(8,750

)

 

$

(4,163

)

Finance costs, net

 

4,423

 

 

 

4,711

 

Income taxes

 

6,754

 

 

 

4,685

 

Depreciation and amortization

 

4,014

 

 

 

3,702

 

EBITDA

$

6,441

 

 

$

8,935

 

 

 

 

 

 

 

 

For the three months ended

 

March 31,
2025

 

March 31,
2024

EBITDA

$

6,441

 

 

$

8,935

 

Change in fair value of biological assets

 

(2,724

)

 

 

(2,675

)

Change in fair market value of derivative

 

(457

)

 

 

(1,687

)

Professional fees(1)

 

74

 

 

 

1,789

 

One-time employee costs(2)

 

133

 

 

 

160

 

Share-based compensation

 

25

 

 

 

49

 

Loss on disposal of assets

 

-

 

 

 

212

 

Other non-recurring expense

 

12

 

 

 

2

 

Adjusted EBITDA

$

3,504

 

 

$

6,785

 

 

 

 

(1) Legal and professional fees associated with potential transactions and professional fees associated with prior periods.

(2) Severance and relocation costs.